Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

AKROAKRO
Showing 6 of 27 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in AKERO THERAPEUTICS INC

As of its Q3 2025 13F, Janus Henderson held 6,280,305 shares of AKRO (Akero Therapeutics), worth $298.2M. Janus Henderson's 13F filings listed AKRO from Q2 2019 to Q3 2025, 26 quarterly filings. AKRO was 0.1% of Janus Henderson's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$203.1M

Total Shares Change

-7.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$47.62
0
2025-Q3
Decreased
6.3M
-6.8%
$298.2M0.1%$47.62
0
2025-Q2
Decreased
6.7M
-4.7%
$359.5M0.2%$56.19
0
2025-Q1
Increased
7.1M
+17.1%
$301.9M0.2%$42.72
43
2024-Q4
Decreased
6M
-14.7%
$167.8M0.1%$27.96
0
2024-Q3
Increased
7.1M
+2.9%
$203.1M0.1%$28.24
38

Other major holders of AKRO: BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used